检索

期
标题
作者
卷 36, 编号 7 (2025)
Rehabilitation as a required stage in the treatment of the consequences of COVID-19
Avdeeva K., Shcherbinina A., Petelina T., Gorbachevsky A.
PDF
(Rus)
卷 28, 编号 7 (2017)
COMORBIDITY AND POLYPRAGMACY
Shlshkova V.
PDF
(Rus)
卷 29, 编号 11 (2018)
A rational approach to solving cardiometabolic problems in the therapy of comorbid patients
Shishkova V., Kapustina L.
PDF
(Rus)
卷 35, 编号 1 (2024)
Sulodexide in clinical practice: possibilities and prospects of its use
Morozov A., Sergeev A., Boltik A., Aslakhanova E., Ispieva K.
PDF
(Rus)
卷 34, 编号 11 (2023)
Assessment of comorbid pathology in patients with breast cancer
Orlova D., Stolyarova V., Skopina Y., Shokina S., Davydova E.
PDF
(Rus)
卷 33, 编号 6 (2022)
Comprehensive prevention of age-related and cardiovascular diseases: the use of the Russian natural remedy BioDihydroquercetin of the Baikal Legend trade mark
Dedov D.
PDF
(Rus)
卷 32, 编号 1 (2021)
Features of the course of cardiovascular pathology and type 2 diabetes mellitus in patients with COVID-19
Polozova E., Skvortsov V., Chegodaeva L., Kurkina N., Prokhorova T., Al-Zakhar N., Nefedov N.
PDF
(Rus)
卷 34, 编号 5 (2023)
Cardiotone: pharmacological properties of hawthorn blood-red, possibility of use in patients with cardiovascular diseases
Dedov D.
PDF
(Rus)
卷 26, 编号 6 (2015)
RISK FACTORS FOR CARDIOVASCULAR DISEASES AND THE RATE OF AGEING IN MEN
Golovanova E.
PDF
(Rus)
卷 24, 编号 5 (2013)
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN REAL PRACTICE: INEQUALITY OF EQUALS
Chernyavskaya T.
PDF
(Rus)
卷 32, 编号 10 (2021)
The main aspects of using magne preparations in complex therapy of a comorbid patient with arterial hypertension
Skvortsov V., Sabanov A., Rodionova I., Gorbach A.
PDF
(Rus)
卷 30, 编号 9 (2019)
POSSIBILITIES OF USING MELDONIUM ORGANICA IN THE COMBINATION TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
Potupchik T., Evert L., Averyanova O., Akhmeldinova Y., Ivanov A.
PDF
(Rus)
卷 36, 编号 4 (2025)
Periodontitis is a modifier of cardiovascular disease
Redinova T., Savelyeva T., Yangirova A., Prilukova N., Biktimerova O.
PDF
(Rus)
卷 34, 编号 3 (2023)
Psychodynamic aspects of some cardiac diseases: a cardiologist’s opinion
Eremeev A.
PDF
(Rus)
卷 28, 编号 8 (2017)
COMBINED THERAPY FOR PANIC DISORDERS IN CARDIOLOGY PRACTICE
Vasilyeva A., Karavaeva T., Poltorak S.
PDF
(Rus)
卷 26, 编号 4 (2015)
ATTENTION! A MOTOR TRANSPORT DRIVER AT THE RECEPTION
Elgarov A., Kalmykova M., Elgarov M.
PDF
(Rus)
卷 23, 编号 9 (2012)
KORREKTsIYa DEFITsITA MAGNIYa KRAEUGOL'NYY KAMEN' NEYROPROTEKTsII I NEYROPLASTIChNOSTI
Akarachkova E., Vershinina S.
PDF
(Rus)
卷 32, 编号 8 (2021)
Hypertrophic cardiomyopathy and pregnancy
Ignatenko G., Taradin G., Kugler T.
PDF
(Rus)
卷 30, 编号 9 (2019)
AN IDEAL CARDIOVASCULAR RISK BIOMARKER - WHAT IS IT?
Dyleva Y., Gruzdeva O., Uchasova E.
PDF
(Rus)
卷 35, 编号 9 (2024)
Clinical and pathogenetic aspects of oxidative stress, the possibility of prophylactic use of the domestic drug Gemonorm
Dedov D.
PDF
(Rus)
卷 28, 编号 3 (2017)
EPIDEMIOLOGY OF HYPERTENSION IN WORKING WOMEN
Elgarov A., Kalmykova M., Apsheva E., Elgarov M., Shogenova A.
PDF
(Rus)
卷 26, 编号 4 (2015)
CHRONIC OBLITERATING DISEASES OF THE LOWER EXTREMITY ARTERIES: PROGNOSTIC VALUE OF CARDIOVASCULAR RISK FACTORS
Lazutkina A., Gorbunov V.
PDF
(Rus)
卷 23, 编号 6 (2012)
POTASSIUM AND MAGNESIUM PREPARATIONS IN ROUTINE CLINICAL PRACTICE
Kubynin A.
PDF
(Rus)
卷 32, 编号 5 (2021)
Cause-of-death coding as a factor influencing mortality rates from individual causes
Samorodskaya I.
PDF
(Rus)
卷 30, 编号 7 (2019)
IMPACT OF STRESS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES
Potupchik T., Evert L., Averyanova O., Akhmeldinova Y.
PDF
(Rus)
卷 29, 编号 5 (2018)
Safe therapy for joint and back pain in a patient with comorbidity
Shishkova V.
PDF
(Rus)
卷 27, 编号 8 (2016)
CONTROL OF CARDIOVASCULAR DISEASES IN RURAL DWELLERS: SURVEY RESULTS
Gomova T., Soin I., Kushunina D., Kalinina A.
PDF
(Rus)
卷 26, 编号 3 (2015)
TREATMENT OF MILD AND MODERATE MAJOR DEPRESSIVE DISORDER WITH VALDOXANE (AGOMELATINE) IN PATIENTS WITH CARDIOVASCULAR DISORDERS: RESULTS OF THE NATIONAL OBSERVATIONAL MULTICENTER STUDY «PULSE»
Medvedev V.
PDF
(Rus)
卷 33, 编号 10 (2022)
OVERVIEW OF MOBILE APPLICATIONS USED BY PHYSICIANS AND PATIENTS WITH CARDIOVASCULAR DISEASES
Rozhnev V., Duvanova S., Sadovnikov A., Zakutnaya E., Gorbunova E.
PDF
(Rus)
卷 32, 编号 4 (2021)
MAIN GROUPS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITORS: MECHANISMS OF ACTION AND CLINICAL EFFICACY. PART 2
Chaulin A., Svechkov N., Volkova S.
PDF
(Rus)
卷 29, 编号 1 (2018)
Comorbidity in patients with type 2 diabetes mellitus
Voloshinova E., Lobanova O., Kunitsyna M., Grlgoryeva E., Tsaturova K.
PDF
(Rus)
卷 27, 编号 9 (2016)
SAFE THERAPY FOR OSTEOARTHRITIS IN PATIENTS WITH COMORBIDITIES
Shishkova V.
PDF
(Rus)
卷 33, 编号 9 (2022)
The drug Cardioton: composition, pharmacological properties, the possibilities of preventing cardiovascular diseases
Dedov D.
PDF
(Rus)
卷 32, 编号 3 (2021)
Main groups of proprotein convertase subtilisin/kexin type 9 inhibitors: mechanisms of action and clinical efficacy. Part 1
Chaulin A., Svechkov N., Volkova S.
PDF
(Rus)
卷 27, 编号 8 (2016)
ADIPONECTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS
Pashentseva A., Verbovoy A., Sharonova L.
PDF
(Rus)
卷 24, 编号 9 (2013)
BISOPROLOL IN PATIENTS WITH CARDIOVASCULAR DISEASES
Zadionchenko V., Shekhyan G., Yalymov A.
PDF
(Rus)
卷 34, 编号 8 (2023)
Possibility of using Femoklim in menopause women with cardiovascular pathologies
Dedov D., Denisova A., Moiseeva I., Petrova E., Poluboyarinov P., Vikhrev D., Panina E., Fedorov A., Burmistrova S.
PDF
(Rus)
卷 28, 编号 9 (2017)
INSULIN RESISTANCE AND DISEASES OF THE INTERNAL ORGANS
Verbovoy A., Sharonova L., Pashentseva A., Verbovaya N., Galkin R.
PDF
(Rus)
卷 27, 编号 9 (2016)
LEPTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS
Pashentseva A., Verbovoy A., Kosareva O.
PDF
(Rus)
卷 33, 编号 6 (2022)
The role of uric acid in the development of cardiovascular diseases: from molecular mechanisms to clinical manifestations
Kunitskaya N., Ariev A., Nemirovskiy V.
PDF
(Rus)
卷 31, 编号 9 (2020)
Prevalence, risk factors, and diagnosis of comorbidity of chronic obstructive pulmonary disease and cardiovascular disease
Chaulin A., Milyutin I., Duplyakov D.
PDF
(Rus)
卷 34, 编号 7 (2023)
Erectile dysfunction in men with cardiovascular disease: the possibility of prevention with Eromax
Dedov D.
PDF
(Rus)
卷 28, 编号 4 (2017)
COENZYME Q10 WITH GINKGO IN CARDIOLOGY PRACTICE
Potupchlk T., Veselova O., Evert L., Makarova M.
PDF
(Rus)
卷 26, 编号 11 (2015)
CARDIOMAGNYL: EFFICACY AND SAFETY
Potupchik T., Veselova O., Evert L., Okladnikova E., Anisimova M., Bryukhanova I.
PDF
(Rus)
卷 24, 编号 5 (2013)
BISOPROLOL IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
Shavarov A.
PDF
(Rus)
卷 33, 编号 5 (2022)
Structured programs for the management of patients with non-alcoholic fatty liver disease in the work of a general practitioner
Skvortsov V., Ustinova M.
PDF
(Rus)
卷 31, 编号 5 (2020)
Cardiovascular diseases prediction by integrated risk factors assessment by means of machine learning
Gavrilov D., Serova L., Korsakov I., Gusev A., Novitsky R., Kuznetsova T.
PDF
(Rus)
1 - 47 的 47 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语